- Home
- MYE vs ATXS Comparison
MYE vs ATXS Comparison
Compare MYE & ATXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYE
- ATXS
- Stock Information
- Founded
- MYE 1933
- ATXS 2008
- Country
- MYE United States
- ATXS United States
- Employees
- MYE N/A
- ATXS N/A
- Industry
- MYE Auto Parts:O.E.M.
- ATXS Biotechnology: Pharmaceutical Preparations
- Sector
- MYE Consumer Discretionary
- ATXS Health Care
- Exchange
- MYE Nasdaq
- ATXS Nasdaq
- Market Cap
- MYE 451.6M
- ATXS 401.2M
- IPO Year
- MYE N/A
- ATXS 2015
- Fundamental
- Price
- MYE $12.69
- ATXS $4.76
- Analyst Decision
- MYE Hold
- ATXS Strong Buy
- Analyst Count
- MYE 1
- ATXS 7
- Target Price
- MYE N/A
- ATXS $32.43
- AVG Volume (30 Days)
- MYE 198.2K
- ATXS 625.9K
- Earning Date
- MYE 05-01-2025
- ATXS 05-13-2025
- Dividend Yield
- MYE 4.25%
- ATXS N/A
- EPS Growth
- MYE N/A
- ATXS N/A
- EPS
- MYE 0.28
- ATXS N/A
- Revenue
- MYE $835,929,000.00
- ATXS N/A
- Revenue This Year
- MYE $1.84
- ATXS N/A
- Revenue Next Year
- MYE $2.02
- ATXS N/A
- P/E Ratio
- MYE $45.29
- ATXS N/A
- Revenue Growth
- MYE 3.92
- ATXS N/A
- 52 Week Low
- MYE $9.06
- ATXS $3.56
- 52 Week High
- MYE $17.39
- ATXS $12.92
- Technical
- Relative Strength Index (RSI)
- MYE 62.64
- ATXS 54.89
- Support Level
- MYE $11.86
- ATXS $3.83
- Resistance Level
- MYE $12.95
- ATXS $4.98
- Average True Range (ATR)
- MYE 0.29
- ATXS 0.45
- MACD
- MYE 0.01
- ATXS 0.11
- Stochastic Oscillator
- MYE 68.03
- ATXS 82.93
About MYE Myers Industries Inc.
Myers Industries Inc designs, manufactures, and markets a variety of plastic, metal, and rubber products, including a broad selection of plastic reusable containers, pallets, small parts bins, bulk shipping containers, storage and organization products, OEM parts, custom plastic products, consumer fuel containers and tanks for water, fuel and waste handling. It operates through the following segments: The Material Handling segment manufactures a selection of durable plastic reusable products that are used repeatedly during the course of their service life. The Distribution segment is engaged in the distribution of equipment, tools, and supplies used for tire servicing and automotive under-vehicle repair, etc. It generates the majority of its revenue from the Material Handling segment.
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.